Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system.

Tomlinson KC, Gardiner SM, Hebden RA, Bennett T.

Pharmacol Rev. 1992 Mar;44(1):103-50. Review. No abstract available.

PMID:
1557425
2.

Central effects of substance P and somatostatin in conscious, streptozotocin-treated rats.

Tomlinson KC, Gardiner SM, Bennett T.

Am J Physiol. 1990 Sep;259(3 Pt 2):R405-10.

PMID:
1697738
3.

Central effects of angiotensins I and II in conscious streptozotocin-treated rats.

Tomlinson KC, Gardiner SM, Bennett T.

Am J Physiol. 1990 May;258(5 Pt 2):R1147-56.

PMID:
2140024
4.

Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats.

Tomlinson KC, Gardiner SM, Bennett T.

Am J Physiol. 1990 Apr;258(4 Pt 2):R852-9.

PMID:
2139547
5.

Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.

Tomlinson KC, Gardiner SM, Bennett T.

J Cardiovasc Pharmacol. 1990 Apr;15(4):562-8.

PMID:
1691384
6.

Diabetes mellitus in Brattleboro rats: cardiovascular, fluid, and electrolyte status.

Tomlinson KC, Gardiner SM, Bennett T.

Am J Physiol. 1989 Jun;256(6 Pt 2):R1279-85.

PMID:
2735454

Supplemental Content

Loading ...
Support Center